michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good morning, Jon.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The messaging is that our -- important messaging is that our target is $250 million without that joint venture. And as we know, that joint venture was done at levels that are accretive to FFO. But, whether they fall at the tail end of this year or they slide into next year, the messaging is really about deals in addition to that as those will be the primary drivers of FFO growth. Remember, the VA portfolio is accretive to FFO, but really a driver of CAD.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I wouldn't, I mean -- yes, that's stretch, but I wouldn't call it unrealistic for delivering a value proposition. And remember this Brady, beyond brokered freight, which is clearly our focus now. We think the same product should work in a modified format, but should work for the shipper market, which is a $250 million market. Because I know, as of right now, at Triumph Business Capital, for example, 70% of the invoices we purchased from truckers are brokered freight, but 30% our shippers. And so, obviously, that means we have trucking customers who haul both in the brokered market, but they also haul directly for shippers.
So our view is if this works and with further feature sets and enhancements, is well, where else are truckers hauling, where else does this issue present itself. And that would be with the larger shipper market. So that's -- and that's a certainly two to three years down the road plan. We've got a lot of work in front of us, just to attack what is right in front of us. And so, in light of that additional market opportunity Brady, I don't think a $100 billion is out of reach.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So our non-COVID business is growing robustly. And so we have very high confidence that that will continue going forward. We had -- as COVID hit, we were quick to respond and had helped our customers build great tests, but then we also were able to supply them. So what happens is we built a lot of loyalty with some of these key customers and certainly it's been a positive impact for our business during COVID but ultimately now we're working with those customers in their post-COVID activities. And so we have strong confidence in a very robust double-digit growing business for our Life Science business outside of COVID.
What we don't know is what happens with COVID right? Is it huge like it was last year. Is it here, but not as big and so part of -- Brian asked a question earlier about $100 million business, take $65 million business and we're approaching $100 million kind of core business over this next year without any COVID and I think we'd all agree that COVID may not be what it was last year, but it's not likely to go away and so I would describe to you that we have a lot of confidence that we have a robust growing Life Science business for a number of years going forward.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's a good question. We've certainly seen outward migration into really as you look at the Sunbelt areas, the Arizona, the Florida, even Nevada, Texas, Alabama, we've certainly seen housing markets to be very strong. Rental market to be very strong. That transition certainly, creating demand for storage. All of our markets have responded well though. And that's one of the things I think we're pleased with is we've had success across all of our portfolio. But those markets are performing a little bit stronger in those areas and you still have some COVID effect overhang going on with we still continue to have them cycled back yet, the communities haven't solved their return to office, return to the gym, garage, those type of things. So that's still out there.
But our tertiary markets even though they had a great 2020. If you want to look at it compared to some of the other markets are still standing up very strong. So I think there's a lot of factors that we're talking about and that transition you mentioned is one of them.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We don't have an exact answer for that, but if I had to break it, I would say that the effects of increased submissions, increased rates and increased exposure are all roughly equal. So let's call it 1/3 of the growth is increased exposure. But that's a guess.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, Ken, this is Charles. What I'd say is that as always, we balance our investment with expenses with revenue. So as we continue to perform and grow, we'll be adding some of that expense back. We'll be reopening travel fairly soon here, so that will start to flow through, all of it, mostly to support sales and growth. And then as the volume does recover, there will be some throughput of that on the expense side and processing.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Another great question. And respect the ask, we're not going to give guidance in terms of the parameters that have been approved by our board for the repurchase of shares. We spent a lot of time focused on net asset value, focused on the potential future cash flow generation that our aggregate business is capable of.
And we're really excited for a time when investors and analysts start to move away from this robotic and revenue-based analysis, which we think is completely inappropriate when assessing companies in the space.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Appreciate that.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I mean, I think, Tyson, we'll -- depending on the cost of rod and this pricing environment, I suspect we'll be using working capital or building it over the period of, into Q2 and the balance of the year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. So Chris, maybe just to dig a little more into the RSNs, maybe you can just tell us a little bit of what happens next. I think that probably the Dish discussion is ongoing. So I'm just curious if you would accept an agreement with DISH that didn't include them. And then if we kind of think about where you might be with the RSNs, if you come in at the low end of your guidance this year, it could mean a renegotiation of debt or some more liquidity coming in. And I know these are what if scenarios, but I think it would just be helpful. If you could maybe just talk about a little bit of how you're thinking about those scenarios. And then, Lucy, the buyback commentary was very helpful. You certainly were opportunistic last year to take advantage of the share price dislocation. As you think about uses of broadcast cash flow going forward, is it debt reduction? Is it being opportunistic on maybe potential in market station M&A, participating in a diamond recapitalization? Maybe just help us think about uses of broadcast cash.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Okay. Well, if there are no further questions, on behalf of our entire management team, we appreciate your listening to and interest in the call today. Mary Anne and Joe Box are available today to answer any direct questions that we did not cover that we're allowed to answer on the reg FD, reg G and applicable securities laws in Canada. Thank you, again, and we look forward to speaking with you at upcoming investor conferences or on our next earnings call.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Hi, everybody. Just to ask about Evernorth, two aspects there, one with now enhanced capital for deployment, it seems like part of the story for Evernorth is diversifying the service offering beyond the pharmacy benefit focus that it currently has. Can you comment on how quickly and you think you can diversify and what is -- maybe update us on the areas that you're thinking about adding to the capability there and then just basing on Evernorth, there was some talk last year that the PBM selling season, people were renewing for a year because of the pandemic. And do you expect the selling season to have more RFPs than normal this year? Or is it sort of a normal RFP season from what you're seeing so far?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So definitely in the last question, we're looking at all kinds of different resin solutions, post-consumer, biodegradable, everything was on the table in that regard. I think, really the name change is just to say that this is more about the custom nature of the business than it is about the substrate. So does it necessarily mean we would do a different substrate in there? Not necessarily. This kind of custom container is more suited to plastic. Part of the reason that we are in plastics is there are markets that need them. I mean, let's be honest, we're not going to go back to glass in our kitchens and our bathrooms. And so you really -- there just is a need for plastic. But that isn't -- what we've kind of looked and said is that a differentiating element of our business? The answer is no. There are a lot of plastic business out there that are not as customer-focused, that are not as solutions-based focus as our business is becoming. And so really, the name change is more to highlight what we think is unique about the business rather than the substrate.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Sure, David. First, our teams have worked really hard. We like to make the statement. We've made every shipment to every customer during these past 12 months. So, whatever the global pandemic has presented in terms of challenges, our teams have risen up and have met those challenges. So, we're very pleased and feel very fortunate to have that as a fundamental. That also means working throughout our supply chain and working closely with our suppliers. They're important partners to us, with the technology that they bring and the delivery that they bring to us.
So, we're working across the entire supply chain, and we've built our company based on having these critical-enabling materials that help solve our customers' most important problems. And if you build a business based on that, then you need to make sure that you're delivering the products on time, in full. So, we spend a lot of time kind of managing all of the above. We probably won't go into too many details about that, but we spend a lot of time managing all of the above to make sure that we can provide those advanced solutions to our customers.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
If there is any, they will be very fleeting because when the tools are installed they can immediately be loaded. The good thing about mainstream is -- the high-end is difficult because qualification times are 9 to 12 months, mainstream qualification time is usually 30 days or less, sometimes zero. So, we may see a little phase lag in one quarter. That maybe depends, right, in one quarter, there might be a little bit of a drag, but in the next quarter it will be completely gone and likely not at all. Margins will be diminished in the first quarter for that particular tool. But, given how quickly mainstream tools ramp is it would be a very fleeting effect.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey, thanks. A couple of quick ones here for you. First one, just curious, Metromile announced this morning that they're going to now start accepting Bitcoin for premium payments, as well as claims payments. What's your thoughts on that? Any challenges that that presents?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thank you. So I guess, first, can you talk a little bit more about the drivers of your higher same-store NOI growth outlook?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks for taking my question guys. If you could -- I'm interested in -- obviously, you can't talk about the one Garden thing. So I'm going to ask you some questions on the leasing. I noticed you had $5.3 million of lease term, which is $5 million -- approximately $5 million more than it was last year. Maybe if you can give some color on that, what that represents. And then maybe also talk about some of the regional differences, perhaps.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thanks. Will, I wonder if you can give your thoughts on the idea of eliminating 1031 exchange; specifically for the LXP portfolio, what that might mean for the office properties that you're still trying to dispose of and then, how you anticipate that might impact the transaction markets and your growth plans going forward?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think the first question will depend on what the FDA will address -- will require in their complete response letter. They clearly want a study. So that is a subject for discussion and we will elaborate on that once we got clarity following the meeting. We certainly will want to go in making a suggestion. So, your proposal is not an unreasonable one. We will take that into consideration. Regarding resubmitting without additional new data, certainly, this is a venue we will discuss at the meeting as well. I would consider perhaps reinforcing the overall survival analysis as we -- as I mentioned earlier on rather than resubmitting without new data that maybe more convincing argument just in my view. Does that answer your question?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Go ahead, Jesse.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
7,500 units, a lot of labs. So all the other competitors, I don't know. If you have to ask them. I should -- probably that's my only comment on that.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'm going to repeat what Cory said, and I'm going to ask Cory to make some comments. I think the overall tone of what Cory said was the $100 million to $200 million is going to be a challenge. My words would be, and we're up for it, but it's going to be a fight. But maybe there's some other admonishments for further detail, Cory, that you might want to add.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We haven't disclosed that. Just the percentage. The percentage was down 4.7% in April.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, it will be seasonal, you know, during the education season as we'll see some seasonality there. And then it's just going to become a smaller piece -- a smaller percentage of our total. Again, as we're moving the Jamf Connect out of that bucket and as we continue to migrate the remaining straggling account into the cloud.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
You too, Connor.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Thanks, Eric.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
All right. Do you see any other questions?

    Prediction (one of UP, DOWN, SAME): SAME